← Insider buys

Christian Adam Smith bought MMSI once, on May 11, 2026

Chief Commercial Officer at Merit Medical Systems, Inc.

SEC CIK 0002072266 · Filings on SEC.gov ↗

$99KBought
$0Sold
May 13Last buy

Christian Adam Smith's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

1 filing since May 2026, newest first

About Christian Adam Smith

Smith Christian Adam (Christian Adam Smith) is a corporate executive and Chief Commercial Officer (CCO) of Merit Medical Systems, Inc. (NASDAQ: MMSI), where he is also reported as a Section 16 insider in recent U.S. Securities and Exchange Commission filings.( Public insider-trading records list him as Chief Commercial Officer of Merit Medical and document multiple equity and stock transactions in 2026, including Form 4 filings and associated reporting of direct and indirect holdings in company common stock and stock options.( News coverage of these filings notes that, as CCO, he has acquired Merit Medical shares both through grants and through purchases via a 401(k) plan, reinforcing his status as a senior member of the company’s executive leadership team.(

Under the name Adam Smith, he is identified by Merit Medical’s own executive leadership disclosures as Chief Commercial Officer, having joined the company in 2018 and assuming the CCO role in 2025.( In this capacity, he leads the development and expansion of Merit’s global commercial activities, after previously serving as Executive Vice President of Marketing and Franchises and holding leadership roles in the International Division and as EMEA General Manager of Operations.( Prior to joining Merit Medical, he accumulated more than 20 years of experience across the medical device industry, technology startups, and the recreation sector, and he holds a Bachelor of Science in Business Management and Accounting from the University of Phoenix.( His background emphasizes strategy development, building high-performing commercial teams, and driving profitable growth in international markets.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.